Reading this forum1 Oct 2023 10:51
So much is speculative, which is fine, that's the point. Do you believe Cart will progress to trials this year? If yes why not buy on that? If no perhaps keep your powder dry.
Do you think CBR now has PoC on brain cancer therapy? See above.
These are debatable, and rightly so. I have decided that one of these are likely to progress far enough to propel the SP significantly this year.
But I am still seeing The Prevail 3p news deliberately being misunderstood. Tilly, didn't think you would but you have. Other big investors are not going to pay 6p now, because they are not going to be party to the deal prevail have when (if) cart goes clinical. Big investors may well get a premium to 10 day average or indeed get 10 day average as I would like to think HEMO are in a good bargaining position.
So a rise in SP now is a good thing for us already in.
I promise to stop with the 6p when posters stop spreading misinformation on it.
Chances of a hurried RNS because of our super sleuth? I would say low. More likely to get RNS on new investors or cart but very much my guess
Good luck all, enjoy the ride. Remember there is always a time to get off, before the fun stops and you start feeling sickπ